Open AccessEfficacy of Shegan Mahuang Decoction for asthma
Author(s) -
YiFang Zhao,
Xiaoping Pang
Publication year - 2019
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000017845
Subject(s) - medicine , jadad scale , cochrane library , medline , meta analysis , asthma , randomized controlled trial , traditional chinese medicine , traditional medicine , alternative medicine , pathology , political science , law
Background: Shegan Mahuang Decoction (SMD) was used widely for treatment of asthma in China; however, the clinical effect of SMD on asthma was not well concluded. Methods: Seven electronic databases (Medline, Cochrane library, EMBASE database, Chinese National Knowledge Infrastructure, Wanfang database, Chongqing VIP database, and Chinese Biomedicine database) will be searched for randomized controlled trials which meet the eligible criteria. Two reviewers will select studies and extract data independently. Risk of bias will be evaluated using modified Jadad score. Data synthesis will be carried out using RevMan 5.3. Sensitivity analysis and publication bias will also be investigated. Results: This systematic review and meta-analysis will review and synthesis current clinical evidence of SMD for the treatment of asthma. Conclusion: This systematic review and meta-analysis will provide high quality evidence of SMD for the treatment of asthma. Registration: PROSPERO CRD42019141810.